Boston news from FierceBiotech
NewsDeveloper plots sprawling biotech complex near Boston
A developer has blueprinted a sprawling 250-acre biotech complex in the Boston area's thriving life sciences cluster. Patriot Partners says it will negotiate with the town of Burlington for the land Read more...
GSK collaborates on immune disease research
GlaxoSmithKline has inked a five year, $25 million collaboration deal with the Disease Institute of Boston to conduct on immunoinflammation research. GSK and IDI researchers will develop joint grant Read more...
Biogen squares off against Icahn in board battle
The war between Biogen Idec and Wall Street raider Carl Icahn is heating up. The Boston-based biotech has Read more...
Genzyme gets public backing for $200M expansion
Genzyme is getting some public backing for a $200 million expansion project in the south of Ireland. The Cambridge, MA-based biotech plans to hire about 170 people as it expands its manufacturing and Read more...
Follica lands $5.5M in first round
Boston-based Follica has landed $5.5 million in its first round of financing. Interwest Partners led the round and existing investors PureTech Ventures also contributed. Follica is developing a Read more...
VC model raises cash for rare disease drugs
The Wall Street Journal looks at the work of Boston-based venture capitalist Roger Kitterman, who has been able to coax investors to back badly needed therapies with none of the big upside that most Read more...
What's Biogen Idec really worth to Big Pharma?
The Wall Street Journal has dug deep into the numbers at Biogen Idec, raising questions about the real value of the company. Biogen Idec is one of the original pioneers in biotechnology and recently Read more...
Boston officials herald big Genzyme expansion
Genzyme broke ground today on a $150 million expansion on its manufacturing facility on the Charles River in Boston. The expansion will add 90 new workers to the 400 already employed at the plant. Read more...
| Press ReleasesPRESS RELEASE: Genzyme Begins Major Expansion of Boston Manufacturing Facility Genzyme Begins Major Expansion of Boston Manufacturing Facility Project to Support the Increasing Global Need for Genzyme Products Genzyme today broke ground on a significant expansion of its Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets